Diffuse Large B-cell Lymphoma Responds to Tafasitamab plus Lenalidomide

Lymphoma
21/06/2020

[No authors listed] Cancer Discov 2020.

ABSTRACT

Patients with relapsed or refractory diffuse large B-cell lymphoma responded to a novel combination.